The route of delivery suggests that the peptides will be able to interact with the GLP-1 receptors on the vagal afferents of the intestine, as is the case for native GLP-1 in healthy individuals
Experience with oral GLP1 use in diabetes has highlighted this disconnect: tablets are often not viewed as premium products, and the scientific and manufacturing innovation required to enable the oral delivery of biologics can be underappreciated at times reduced to just a pill. This perception gap may pose commercial challenges, especially when oral therapies are priced alongside injectable alternatives
Whether you are using a branded medication filled at your local pharmacy or a compounded option prepared through a pharmacy partner, the level of care and support remains the same
So far, the pill is priced in much the same range as the injection rather than as a cheaper option
But this one stands out because it actually works, and it works naturally
Relationship of gastric emptying or accommodation with satiation, satiety, and postprandial symptoms in health
